Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Disparities in metastatic renal cell carcinoma (mRCC) outcomes persist in the era of oral anticancer agents (OAAs) and immunotherapies (IOs). We examined variation in the utilization of mRCC systemic therapies among US Medicare beneficiaries from 2015 to 2019. Logistic regression models evaluated the association between therapy receipt and demographic covariates including patient race, ethnicity, and sex. In total, 15 407 patients met study criteria. After multivariable adjustment, non-Hispanic Black race and ethnicity was associated with reduced IO (adjusted relative risk ratio [aRRR] = 0.76, 95% confidence interval [CI] = 0.61 to 0.95; P = .015) and OAA receipt (aRRR = 0.76, 95% CI = 0.64 to 0.90; P = .002) compared with non-Hispanic White race and ethnicity. Female sex was associated with reduced IO (aRRR = 0.73, 95% CI = 0.66 to 0.81; P < .001) and OAA receipt (aRRR = 0.74, 95% CI = 0.68 to 0.81; P < .001) compared with male sex. Thus, disparities by race, ethnicity, and sex were observed in mRCC systemic therapy utilization for Medicare beneficiaries from 2015 to 2019.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276895PMC
http://dx.doi.org/10.1093/jncics/pkad036DOI Listing

Publication Analysis

Top Keywords

race ethnicity
12
metastatic renal
8
renal cell
8
cell carcinoma
8
associated reduced
8
disparities immune
4
immune targeted
4
targeted therapy
4
therapy utilization
4
utilization older
4

Similar Publications

This paper will present a case study of local responses to the epidemic in immigrant enclaves and majority-black neighborhoods in Atlanta, Georgia. The COVID-19 health crisis presents an unprecedented challenge for many black and brown communities in the United States which may be particularly vulnerable to the contagion because of higher rates of certain pre-existing conditions like heart disease, lack of access to adequate healthcare services, and financial pressures to continue working despite increasingly risky conditions. In the American South where burgeoning ethnic enclaves, well-establish majority-black neighborhoods, and affluent suburbs exist side by side with vastly different healthcare concerns, disorganized governmental responses to the COVID-19 epidemic highlight the importance of efforts by CBOs (i.

View Article and Find Full Text PDF

The Oncotype DX test is standardly used for patients with early-stage, hormone-receptor-positive, HER2-negative breast cancers to determine the benefit from chemotherapy and the likelihood of distant recurrence. The relationship between Oncotype DX recurrence scores and race/ethnicity is still being studied. This retrospective study aims to evaluate the relationship between Oncotype DX recurrence scores, race/ethnicity, and clinicopathological factors and to support the applicability of the Oncotype DX test for a diverse breast cancer population of Hawaii.

View Article and Find Full Text PDF

A case-control study of end-of-life antimicrobial use in Non-hospitalized hospice patients in the United States.

Antimicrob Steward Healthc Epidemiol

September 2025

Department of Palliative and Supportive Care, The Lois U. and Harry R. Horvitz Palliative Medicine Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Background: Antimicrobials are frequently prescribed to hospice patients despite limited data on their utility. The Palliative Performance Scale (PPS) has been used for survival prediction among cancer patients and further generalized to end-of-life (EOL) diagnoses. This study aims to identify characteristics associated with antimicrobial usage within 30 days of EOL in non-hospitalized outpatient hospice patients from a single center in the United States (US).

View Article and Find Full Text PDF

Trends in Demographics Among Biosafety Professionals: A Decade-Long Analysis.

Appl Biosaf

August 2025

Environmental Science and Health, University of Nevada, Reno, Nevada, USA.

Introduction: This study examines demographic trends among biosafety professionals from 2013 to 2024, focusing on changes in age, race, education, experience, and income. The goal is to inform educational and targeted interventions for the evolving needs of the biosafety profession.

Methods: Surveys were conducted in 2013, 2016, 2020, 2023, and 2024 among ABSA International affiliates and Institutional Biosafety Committee contacts.

View Article and Find Full Text PDF

Objective: To explore symptoms, knowledge levels, perceptions, and use related to menopause and hormone therapy (HT) and to examine the factors associated with HT use and HT perceptions in perimenopausal and postmenopausal women.

Materials And Methods: We used a sample of 98 perimenopausal and postmenopausal women who aged 50-79 and participated in the Sex, ApoE-4, γ-aminobutyric acid, and Episodic memory (SAGE) study ( = 64.24, = 7.

View Article and Find Full Text PDF